Clinical Trial Detail

NCT ID NCT04030559
Title Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors University of California, Davis
Indications

prostate cancer

Therapies

Niraparib

Age Groups: adult senior

Additional content available in CKB BOOST